3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
13
Esophageal Squamous Cell Carcinoma
7
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
4
Rectal Neoplasms
4
Neoplasms
4
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Turcot syndrome
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of External Auditory Canal
1
Seminoma
1
Recurrence
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Muscle Invasive Bladder Cancer
1
Interventions
Etoposide
3
Platinum
2
Cisplatin
2
Bleomycin
2
sodium thiosulfate
1
Radiotherapy
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Hearing
1
Drug Therapy
1
Carboplatin
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Seminoma
×
Neoadjuvant Therapy
×
Clear all
NCT07498959
2026-03-27
TESTIGO
Sahlgrenska University Hospital
Phase NA
Recruiting
160 enrolled